The trading price of Johnson & Johnson (NYSE:JNJ) floating higher at last check on current market day and closing at $168.73, 0.87% higher than its previous close.
The company’s P/E ratio in the trailing 12-month period was 29.10. In examining the 52-week price action we see that the stock hit a 52-week high of $168.85 and a 52-week low of $140.68. Over the past month, the stock has gained 10.90% in value.
Johnson & Johnson, whose market valuation is $406.24 billion at the time of this writing, is expected to release its quarterly earnings report in April. The dividend yield on the company stock is 2.94%, while its Forward Dividend ratio is 4.96. Investors’ optimism about the company’s current quarter earnings report is understandable.
On the technical side, indicators suggest JNJ has a 100% Buy on average for the short term. According to the data of the stock’s medium term indicators, the stock is currently averaging as a 50% Sell, while an average of long term indicators suggests that the stock is currently 50% Buy.
Here is the average analyst rating on the stock as represented by 1.00 to 5.00, with the extremes of 1.00 and 5.00 suggesting the stock should be considered as either strong buy or strong sell respectively. The number of analysts that have assigned JNJ a recommendation rating is 19. Out of them, 8 rate it a Hold, while 11 recommend Buy, whereas 0 assign an Overweight rating. 0 analyst(s) have tagged Johnson & Johnson (JNJ) as Underweight, while 0 advise Sell. Analysts have rated the stock Buy, likely urging investors to take advantage of the opportunity to add to their holdings of the company’s shares.
If we dig deeper into the stock’s outlook, we see that the stock’s PEG is 5.75, which symbolizes a positive outlook. A quick review shows that JNJ’s price is currently 5.91% off the SMA20 and 11.32% off the SMA50. The RSI metric on the 14-day chart is currently showing 74.13, and weekly volatility stands at 1.60%. When measured over the past 30 days, the indicator reaches 1.52%. Johnson & Johnson (NYSE:JNJ)’s beta value is currently sitting at 0.49, while the Average True Range indicator is currently displaying 2.70. With analysts defining $159-$215 as the low and high price targets, we arrive at a consensus price target of $172.5 for the trailing 12-month period. The current price is about 5.77% off the estimated low and -27.42% off the forecast high, based on this estimate. Investors will be thrilled if JNJ’s share price rises to $172.5, which is the median consensus price. At that level, JNJ’s share price would be -2.23% below current price.
To see how Johnson & Johnson stock has been performing today in comparison to its peers in the industry, here are the numbers: JNJ stock’s performance was 0.87% at last check in today’s session, and 4.56% in the past year. Johnson & Johnson has a P/E ratio of 29.10, compared to Procter & Gamble Co.’s 28.56 and Rogers Corp.’s 51.93.
An evaluation of the daily trading volume of Johnson & Johnson (NYSE:JNJ) indicates that the 3-month average is 9.05 million.
Currently, records show that 2.41 billion of the company’s shares remain outstanding. The insiders hold 0.13% of outstanding shares, whereas institutions hold 72.99%. However, since the stock’s price has seen 16.67% year-to-date, investors’ interest is likely to be reignited due to its potential to move even higher.
